This was the first time we have been able to gather since the pandemic and it was wonderful to share a meal together and bond outside of work! Looking forward to more fun together!
Check out a new article on biomarkers in sarcoma in the ASCO daily news! https://dailynews.ascopubs.org/do/10.1200/ADN.21.200505/full/
We are so proud of Andy and Kuangying who both successfully defended their masters theses in December. Congratulations to both of them!
Even though we can’t physically be together in one space, the Hirbe lab virtually celebrated with a surprise baby shower for Himanshi. Uber eats so everyone could have a meal and some fun games as well! Congrats, Himanshi. We are so happy for you!
Sign up here!
Previous two STAR program summer high school students, Neha Amin (Fort Zumwalt South High School; Saint Peters, Missouri) and Natalie Loveridge (Edwardsville High School; Edwardsville, Illinois), are looking forward to a brighter future! Natalie will be starting undergrad at Vanderbilt University in the fall and Neha will be attending Wash U and will be coming back to do research with us […]
Dr. Hirbe traveled to Iowa this weekend to meet with her colleagues in the Midwest Sarcoma Trials Partnership to discuss new clinical trial ideas. Fighting Sarcoma!
We were excited to have Dr. Dana Borcherding to interview to join our lab and even happier that she will be joining us in April!
Happy Chinese New Year! The Hirbe lab had another wonderful Chinese New Year celebration led by Xiao. This year’s special guest was Charlie. He was a little tired, but loved the dumplings!
We were happy to be able to celebrate with James as he completed his Master of Science in Biostatistics! We are excited to have him join the lab full time leading up to beginning a PhD program!
The Hirbe lab is celebrating two big grants which were awarded this month! Dr. Hirbe has joined forces with colleagues at the University of Minnesota (Dr. David Largaespada), Johns Hopkins University (Dr. Christine Pratilas) and Sage Bionetworks (Dr. Sara Gosline) to use the preclinical platform that they have developed to test novel combinations of drugs […]